Results: 1-25 | 26-29
Results: 1-25/29

Authors: Kabelitz, D
Citation: D. Kabelitz, Immunology, of growing clinical value, DEUT MED WO, 126(37), 2001, pp. 997-997

Authors: Conrad, K Steinmann, J Kabelitz, D Rieber, EP
Citation: K. Conrad et al., Clinical significance of autoantibodies, DEUT MED WO, 126(37), 2001, pp. 1005-1010

Authors: Schaffner, G Kabelitz, D
Citation: G. Schaffner et D. Kabelitz, Therapeutic monoclonal antibodies, DEUT MED WO, 126(30), 2001, pp. 851-856

Authors: Schaffner, G Kabelitz, D
Citation: G. Schaffner et D. Kabelitz, Approved monoclonal antibodies for in vivo diagnosis, DEUT MED WO, 126(28-29), 2001, pp. 819-822

Authors: Hinz, T Weidmann, E Kabelitz, D
Citation: T. Hinz et al., Dual TCR-expressing T lymphocytes in health and disease, INT A AL IM, 125(1), 2001, pp. 16-20

Authors: Stepczynska, A Lauber, K Engels, IH Janssen, O Kabelitz, D Wesselborg, S Schulze-Osthoff, K
Citation: A. Stepczynska et al., Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation, ONCOGENE, 20(10), 2001, pp. 1193-1202

Authors: Kabelitz, D Wesch, D
Citation: D. Kabelitz et D. Wesch, Role of gamma delta T-lymphocytes in HIV infection, EUR J MED R, 6(4), 2001, pp. 169-174

Authors: Hinz, T Flindt, S Marx, A Janssen, O Kabelitz, D
Citation: T. Hinz et al., Inhibition of protein synthesis by the T cell receptor-inducible human TDAG51 gene product, CELL SIGNAL, 13(5), 2001, pp. 345-352

Authors: Weidmann, E Boehrer, S Chow, KU Engels, K Harder, L Hinz, T Janssen, O Kriener, S Rummel, MJ Siebert, R Kabelitz, D Hansmann, ML Hoelzer, D Mitrou, PS
Citation: E. Weidmann et al., Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine, ONKOLOGIE, 24(2), 2001, pp. 162-164

Authors: Tchikov, V Winoto-Morbach, S Kabelitz, D Kronke, M Schutze, S
Citation: V. Tchikov et al., Adhesion of immunomagnetic particles targeted to antigens and cytokine receptors on tumor cells determined by magnetophoresis, J MAGN MAGN, 225(1-2), 2001, pp. 285-293

Authors: Kabelitz, D Glatzel, A Wesch, D
Citation: D. Kabelitz et al., Antigen recognition by human gamma delta T lymphocytes, INT A AL IM, 122(1), 2000, pp. 1-7

Authors: Janssen, O Stocker, A Sanzenbacher, R Oberg, HH Siddiqi, MA Kabelitz, D
Citation: O. Janssen et al., Differential regulation of activation-induced cell death in individual human T cell clones, INT A AL IM, 121(3), 2000, pp. 183-193

Authors: Herrnring, C Reimer, T Jeschke, U Makovitzky, J Kruger, K Gerber, B Kabelitz, D Friese, K
Citation: C. Herrnring et al., Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors, HISTOCHEM C, 113(3), 2000, pp. 189-194

Authors: Zavazava, N Kabelitz, D
Citation: N. Zavazava et D. Kabelitz, Alloreactivity and apoptosis in graft rejection and transplantation tolerance, J LEUK BIOL, 68(2), 2000, pp. 167-174

Authors: Weidmann, E Hinz, T Klein, S Schui, DK Harder, S Kriener, S Kabelitz, D Hoelzer, D Mitrou, PS
Citation: E. Weidmann et al., Cytotoxic hepatosplenic gamma delta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biological and clinical features, HAEMATOLOG, 85(10), 2000, pp. 1024-1031

Authors: Janssen, O Sanzenbacher, R Kabelitz, D
Citation: O. Janssen et al., Regulation of activation-induced cell death of mature T-lymphocyte populations, CELL TIS RE, 301(1), 2000, pp. 85-99

Authors: Kabelitz, D
Citation: D. Kabelitz, Role of apoptosis in cardiac allograft vasculopathy, Z KARDIOL, 89, 2000, pp. 21-23

Authors: Weber-Arden, J Wilbert, OM Kabelitz, D Arden, B
Citation: J. Weber-arden et al., V delta repertoire during thymic ontogeny suggests three novel waves of gamma delta TCR expression, J IMMUNOL, 164(2), 2000, pp. 1002-1012

Authors: Hinz, T Kabelitz, D
Citation: T. Hinz et D. Kabelitz, Identification of the T-cell receptor alpha variable (TRAV) gene(s) in T-cell malignancies, J IMMUNOL M, 246(1-2), 2000, pp. 145-148

Authors: Luschen, S Ussat, S Scherer, G Kabelitz, D Adam-Klages, S
Citation: S. Luschen et al., Sensitization to death receptor cytotoxicity by inhibition of Fas-associated death domain protein (FADD)/caspase signaling - Requirement of cell cycle progression, J BIOL CHEM, 275(32), 2000, pp. 24670-24678

Authors: Reimer, T Herrnring, C Koczan, D Richter, D Gerber, B Kabelitz, D Friese, K Thiesen, HJ
Citation: T. Reimer et al., FasL : Fas ratio - A prognostic factor in breast carcinomas, CANCER RES, 60(4), 2000, pp. 822-828

Authors: Hinz, T Allam, A Wesch, D Schindler, D Kabelitz, D
Citation: T. Hinz et al., Cell-surface expression of transrearranged V gamma-C beta T-cell receptor chains in healthy donors and in ataxia telangiectasia patients, BR J HAEM, 109(1), 2000, pp. 201-210

Authors: Marget, M Sharma, BB Tesar, M Kretzschmar, T Jenisch, C Westphal, E Davarnia, P Weiss, E Ulbrecht, M Kabelitz, D Kronke, M
Citation: M. Marget et al., Bypassing hybridoma technology: HLA-C reactive human single-chain antibodyfragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities, TISSUE ANTI, 56(1), 2000, pp. 1-9

Authors: Kabelitz, D
Citation: D. Kabelitz, Immunology: Realizable discoveries, DEUT MED WO, 124(51-52), 1999, pp. 1570-1572

Authors: Kabelitz, D Janssen, O
Citation: D. Kabelitz et O. Janssen, Antigen-induced death of T-lymphocytes, PEDIAT PATH, 18(4-5), 1999, pp. 329-354
Risultati: 1-25 | 26-29